EpiPen maker's CEO set to defend prices amid public outcry

Wednesday, September 21, 2016 - 08:31 in Mathematics & Economics

Mylan faces new scrutiny over price hikes for its anti-allergy EpiPen

Read the whole article on CBC: Health

More from CBC: Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net